Keywords: safinamide, raises, time, hrs, ph, iii, trial

Safinamide raises "on" time by 1.3 hrs in Ph III trial

Article | 09 February 2009

Print This

Italy's Newron Pharmaceuticals SpA and its partner, German drugmaker Merck Serono, says that the first Phase III trial of safinamide ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in